Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
Latest action · Sep 30, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedSep 27, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
Cosponsors 4
Members who signed on, in the order they did. Signatures ran from Sep 27, 2019 to Oct 31, 2019; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-NE | Jeff Fortenberry | Original | Sep 27, 2019 |
| D-TX | Marc A. Veasey | Original | Sep 27, 2019 |
| R-KS | Roger Marshall | Original | Sep 27, 2019 |
| R-WI | Bryan Steil | Oct 31, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Sep 27, 2019 |
| Health Subcommittee | Referred Sep 30, 2019 |
Actions 3
Everything that happened, newest first.
- Sep 30, 2019Referred to the Subcommittee on Health.
- Sep 27, 2019Introduced in House
- Sep 27, 2019Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 173, October 31, 2019.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome, Nipah, and Rift Valley fever.
- Short Title(s) as Introduced
- Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Sep 27, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.